Loss of hypoglycemia awareness in an adolescent with type 1 diabetes mellitus during treatment with fluoxetine hydrochloride.
A 17-year-old boy with type 1 diabetes mellitus developed new loss of hypoglycemia awareness while being treated with fluoxetine hydrochloride for depression. Hypoglycemia unawareness resolved after this medication was discontinued.
Sawka
A M
AM
Mayo Clinic, Department of Pediatrics and Department of Endocrinology, Metabolism, and Nutrition, Rochester, MN 55905, USA.
Burgart
V
V
Zimmerman
D
D
D000293:Adolescent; D001364:Awareness / Q000187:drug effects*; D003863:Depression / Q000188:drug therapy* / Q000209:etiology*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000523:psychology*; D005473:Fluoxetine / Q000009:adverse effects*; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology* / Q000523:psychology*; D008297:Male; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors